CrossRef Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension Jun Sung Moon, Kyung-Ah Han, Jae Myung Yu, Jong Chul Won, Jun Goo Kang, Soojin Park, Cheol-Young Park Diabetes Research and Clinical Practice.2026
Int J Mol Sci 22(21):11847 Jrgenson M, Zharkovskaja T, Noortoots A, Morozova M, Beniashvili A, Zapolski M, Zharkovsky A (2019) Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimers disease
Their ability to accumulate means they can be used as reserves when dietary intake is insufficient
Caspase-1 Engages Full-Length Gasdermin D through Two Distinct Interfaces That Mediate Caspase Recruitment and Substrate Cleavage